Sanofi Sues Eli Lilly, Alleging Insulin Patent Infringement

French drugmaker Sanofi has filed a lawsuit against Eli Lilly and Co., accusing the U.S. drugmaker of infringing upon patents that protect its insulin Lantus.

Sanofi said Thursday after markets closed that its lawsuit, filed in U.S. District Court, alleges the infringement of four patents, and the case was triggered by a notification from Lilly that it had submitted an application for approval to the U.S. Food and Drug Administration.

Indianapolis-based Lilly is seeking approval for a potential long-lasting insulin labeled LY2963016 that it developed with German drugmaker Boehringer Ingelheim. The company said on Friday that its insulin does not infringe on the patents.

Insulin helps people with diabetes, a chronic condition in which the body either does not make enough insulin to break down the sugar in foods or uses it inefficiently. Diabetes, which is growing rapidly worldwide, can cause early death or serious complications like blindness or heart disease.

The litigation could delay a possible FDA approval of the Lilly drug, and it gives Sanofi more time to switch to a new and improved version, Bernstein analyst Dr. Tim Anderson said in a research note.

"For (Lilly), on the other hand, the delay merely means that it will have to sit on its hands a bit longer before launching its version of Sanofi's drug," the analyst wrote in a research note.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2819274, ~/Articles/ArticleHandler.aspx, 9/5/2015 12:47:24 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Associated Press

Today's Market

updated 15 hours ago Sponsored by:
DOW 16,102.38 -272.38 -1.66%
S&P 500 1,921.22 -29.91 -1.53%
NASD 4,683.92 -49.58 -1.05%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes